Last Updated: November 9, 2026

CLINICAL TRIALS PROFILE FOR QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

« Back to Dashboard

All Clinical Trials for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00515021 ↗	Diurnal Variation of Plasminogen Activator Inhibitor-1	Completed	National Center for Research Resources (NCRR)	Phase 4	2007-04-01	To determine if nighttime administration of an aldosterone antagonist would effectively lower peak plasma Plasminogen Activator Inhibitor-1 (PAI-1) levels more effectively than morning administration.
NCT00515021 ↗	Diurnal Variation of Plasminogen Activator Inhibitor-1	Completed	Vanderbilt University Medical Center	Phase 4	2007-04-01	To determine if nighttime administration of an aldosterone antagonist would effectively lower peak plasma Plasminogen Activator Inhibitor-1 (PAI-1) levels more effectively than morning administration.
NCT00648011 ↗	Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg	Completed	Mylan Pharmaceuticals	Phase 1	2003-08-01	The objective of this study was to investigate the bioequivalence of Mylan's quinapril HCl and hydrochlorothiazide 20 mg/25 mg tablets to Parke-Davis' Accuretic™ 20mg/ 25 mg tablets following a single, oral 20/25 mg (1 x 20/25 mg) dose administration under fed conditions.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Condition Name

Chart
Table

Condition Name for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Intervention	Trials
Healthy	4
Hypertension	2
Metabolic Syndrome X	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Intervention	Trials
Hypertension	2
Metabolic Syndrome	1
Diabetes Mellitus, Type 2	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Trials by Country

Map
Table

Trials by Country for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Location	Trials
United States	3
India	2
Turkey	2
Romania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Location	Trials
North Dakota	2
Tennessee	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Clinical Trial Phase	Trials
Phase 4	3
Phase 1	2
N/A	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Clinical Trial Phase	Trials
Completed	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Sponsor Name

Chart
Table

Sponsor Name for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Sponsor	Trials
Mylan Pharmaceuticals	2
Ranbaxy Laboratories Limited	2
National Center for Research Resources (NCRR)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Sponsor	Trials
Industry	6
NIH	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.